AstraZenecas

AstraZeneca, commonly known as AstraZeneca, is a British-Swedish multinational pharmaceutical company. Founded in 1999 through the merger of Sweden's Astra AB and the United Kingdom's Zeneca Group, the company is headquartered in Cambridge, United Kingdom, with research and manufacturing operations globally.

The company develops prescription medicines and vaccines across multiple therapeutic areas, including cardiovascular and metabolic diseases, oncology, respiratory, immunology, and neuroscience. Notable products include several cancer therapies and cardiovascular drugs; it also develops vaccines, including Vaxzevria, a COVID-19 vaccine co-developed with Oxford University.

R&D and manufacturing activities are conducted through major centers and facilities around the world, with a emphasis on innovative medicines, biologics, and partnerships. The company maintains a broad global presence, operating in more than 100 countries and supplying products to markets worldwide.

Corporate presence and governance are characterized by a dual listing on major stock exchanges, with trading on the London Stock Exchange and at times on the Nasdaq, reflecting its international investor base. AstraZeneca remains one of the largest pharmaceutical companies by market influence, focusing on long-term research pipelines and collaborations across biopharmaceutical sectors.